Literature DB >> 26068761

Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness.

Gisela Caceres1, John A Puskas, Anthony M Magliocco.   

Abstract

BACKGROUND: Circulating tumor cells (CTCs) are an important diagnostic tool for understanding the metastatic process and the development of cancer.
METHODS: This review covers the background, relevance, and potential limitations of CTCs as a measurement of cancer progression and how information derived from CTCs may affect treatment efficacy. It also highlights the difficulties of characterizing these rare cells due to the limited cell surface molecules unique to CTCs and each particular type of cancer.
RESULTS: The analysis of cancer in real time, through the measure of the number of CTCs in a " liquid" biopsy specimen, gives us the ability to monitor the therapeutic efficacy of treatments and possibly the metastatic potential of a tumor.
CONCLUSIONS: Through novel and innovative techniques yielding encouraging results, including microfluidic techniques, isolating and molecularly analyzing CTCs are becoming a reality. CTCs hold promise for understanding how tumors work and potentially aiding in their demise.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26068761     DOI: 10.1177/107327481502200207

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  12 in total

Review 1.  Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.

Authors:  Jian Zhou; Ao Huang; Xin-Rong Yang
Journal:  J Gastrointest Cancer       Date:  2016-06

Review 2.  Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer.

Authors:  Margherita Correnti; Chiara Raggi
Journal:  Oncotarget       Date:  2017-01-24

3.  [Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study].

Authors:  Huanhuan Lian; Zhidan Ding; Dongfeng Yuan; Jie Ma; Jianjun Qin
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-12-20

Review 4.  The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer.

Authors:  Joanna Kapeleris; Arutha Kulasinghe; Majid E Warkiani; Ian Vela; Liz Kenny; Kenneth O'Byrne; Chamindie Punyadeera
Journal:  Front Oncol       Date:  2018-08-14       Impact factor: 6.244

Review 5.  Tumor progression mechanisms: Insights from the central immune regulation of tissue homeostasis.

Authors:  Natalya Lisovska; Nasrulla Shanazarov
Journal:  Oncol Lett       Date:  2019-04-05       Impact factor: 2.967

6.  The Frequency of Circulating Tumour Cells and the Correlation with the Clinical Response to Standard Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Prospective Study.

Authors:  Yu Qian; Yuan Wu; Zilong Yuan; Xiaohui Niu; Yaoyao He; Jun Peng; Fuxiang Zhou; Shaozhong Wei; Desheng Hu; Yunfeng Zhou
Journal:  Cancer Manag Res       Date:  2019-12-02       Impact factor: 3.989

7.  First-in-Human Phase 1 Trial of Agarose Beads Containing Murine RENCA Cells in Advanced Solid Tumors.

Authors:  Barry H Smith; Tapan Parikh; Zoe P Andrada; Thomas J Fahey; Nathaniel Berman; Madeline Wiles; Angelica Nazarian; Joanne Thomas; Anna Arreglado; Eugene Akahoho; David J Wolf; Daniel M Levine; Thomas S Parker; Lawrence S Gazda; Allyson J Ocean
Journal:  Cancer Growth Metastasis       Date:  2016-08-02

Review 8.  Biomarkers could facilitate prediction of worse clinical outcome of cancer with special insight to cervical cancer.

Authors:  Bartosz Czerniak; Dorota Olszewska-Słonina
Journal:  Contemp Oncol (Pozn)       Date:  2018-04-03

Review 9.  [Blood-based Tumor Markers in Lung Cancer].

Authors:  Caicun Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-12

10.  Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma.

Authors:  Ying Yu; Zhi-Xiu Lin; Hai-Wen Li; Hai-Qing Luo; Dong-Hong Yang; He-Chao Zhou; Dan-Xian Jiang; De-Chao Zhan; Liu Yang; Xiao-Ye Liang; Zhong-Hua Yu; Zi-Hong Chen
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.